Despite the coronavirus Delta variant, the stock rally continues, with the Dow surpassing 35K for the first time. So what gives? Read More
Analyst Articles
Second-quarter operating results so far from the S&P 500 are crushing expectations, a stellar performance that’s helping propel stocks to new highs. Read More
The deadlier and more contagious coronavirus mutation is a threat to public health and the economy, but paradoxically, it's manna for pot sales. Read More
As stock markets around the world bounce back from the latest bout of COVID jitters, overseas equities offer future growth at a discount. Read More
Wall Street's mood has suddenly brightened, as investors turn their attention from COVID to economic growth. We pinpoint under-the-radar opportunities. Read More
Financial services access for marijuana businesss is improving, indicating the day is at hand when pot companies no longer need to operate as “cash only.” Read More
The sudden rise of coronavirus infection rates around the world is frightening investors. Here’s a look at the bad news, along with reasons for optimism. Read More
Despite bullish conditions, the markets face many perils. Here’s how to stay invested, while minimizing exposure to potential calamities. Read More
Inflation? COVID Delta? High valuations? The markets are vulnerable to headline risk. Here’s how to brace your portfolio for the next bombshell news report. Read More
The top leader in the U.S. Senate this week introduced legislation to decriminalize cannabis, a political milestone that’s cheering pot investors. Read More